PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Intensive Care Department, Hospital Universitari de Bellvitge, L\'Hospitalet de LL., Barcelona, Spain. gabriel.moreno@bellvitgehospital.cat.\', \'Bellvitge Biomedical Research Institute (IDIBELL), L\'Hospitalet de LL., Barcelona, Spain. gabriel.moreno@bellvitgehospital.cat.\', \'Bellvitge Biomedical Research Institute (IDIBELL), L\'Hospitalet de LL., Barcelona, Spain.\', \'Clinical Hematology Department, Institut Català d\' Oncologia, L\'Hospitalet de LL., Barcelona, Spain.\', \'Infectious Disease Department, Hospital Universitari de Bellvitge, L\'Hospitalet de LL., Barcelona, Spain.\', \'Spanish Network for Research in Infectious Disease (REIPI), Instituto de Salud Carlos III, Madrid, Spain.\', \'Immunology Department, Hospital Universitari de Bellvitge, L\'Hospitalet de LL., Barcelona, Spain.\', \'Barcelona University, Barcelona, Spain.\', \'Clinical Oncology Department, Institut Català d\' Oncologia, L\'Hospitalet de LL., Barcelona, Spain.\', \'Clinical Trials Unit, Institut Català d\' Oncologia, L\'Hospitalet de LL., Barcelona, Spain.\', \'Oncology Emergency Unit, Institut Català d\' Oncologia, L\'Hospitalet de LL., Barcelona, Spain.\', \'Pharmacology Department, Institut Català d\' Oncologia, L\'Hospitalet de LL., Barcelona, Spain.\', \'Palliative Department, Institut Català d\' Oncologia, L\'Hospitalet de LL., Barcelona, Spain.\', \'Intensive Care Department, Hospital Universitari de Bellvitge, L\'Hospitalet de LL., Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-021-05072-4
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33546739
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33546739>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33546739>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all